Benchmark Reiterates Buy on ICU Medical Following Management Meetings

By: Benzinga
In a report published Monday, Benchmark Company analyst James Terwilliger reiterated a Buy rating and $69.00 price target on ICU Medical (NASDAQ: ICUI ). In the report, Terwilliger noted, “We were recently marketing with a member of the ICU Medical management team, and we remain comfortable with our 2013 revenue
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.